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 Abstract 
 Background: Abdominal surgery is frequently followed by immune dysfunction usually last-
ing for several days. This is especially important in cases with tumour diseases as an intact 
immune function is essential in this situation. Therefore, we analysed the outcome of tumour-
bearing mice in a mouse model of surgically induced immune dysfunction (SID).  Methods: In 
male C57BL/6 mice, a pancreatic tumour was implanted orthotopically. Following tumour im-
plantation, the model of SID was applied. The control groups were either laparotomised or 
underwent no surgical procedure. The survival rate was determined by observation for >60 
days. The tumour growth progress was imaged by a 7-tesla small animal MRI.  Results: On day 
60 after tumour implantation, the survival rate in SID mice was reduced to 41%. In the lapa-
rotomised group, 81% of mice survived, while the control group had a survival rate of 75%. 
These differences were significant (SID vs. control: p < 0.02, and SID vs. laparotomy: p < 0.002). 
The tumour volume was not influenced by the degree of surgical trauma.  Conclusion: In pan-
creatic cancer, the SID model is ideally suited to investigate the influence of SID on this tumour 
entity.  © 2014 S. Karger AG, Basel 
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 Introduction 
 In patients with malignant diseases, tumours often lead to severe immunosuppression. 
Additional dysfunctions of the immune system will further impair the prognosis of these 
patients. Surgery is almost always associated with a general state of immunosuppression. 
Abdominal surgery, in particular, is frequently followed by an immune dysfunction usually 
lasting for several days. Surgical procedures induce an imbalance of the immune function 
comparable to the course of sepsis including hypo- and hyper-inflammatory phases  [1–4] . 
Yet, the duration of immunosuppression is not exactly known. It is believed to depend on the 
severity of the previous surgical trauma including duration and type of surgery.
 In humans, the severity of immunosuppression is mirrored by the expression of HLA-DR 
(MHC class II cell surface receptor) on circulating monocytes  [4, 5] . In the postoperative 
period, HLA-DR expression is significantly lower after major surgery, including pancreatic 
resections and colorectal surgery, than after minor surgery, such as cholecystectomies. In this 
context, the extent of surgical trauma has an important impact on surgically induced immu-
nosuppression. This is particularly true for the duration of surgery as well as the use of mini-
mally invasive techniques versus open surgery  [6] . Procedures that last >2.5 h result in a 
decreased HLA-DR expression of monocytes compared to  short-time surgery  [7] .  In particular, 
more complex tumour surgery, such as pancreatic or multivisceral resections, can largely 
extend this time frame. However, HLA-DR is expressed only by humans and therefore not a 
useful marker in mouse models. Nevertheless, surgery- and trauma-induced severe immuno-
suppression is also seen in equivalent murine models  [8–11] .
 Despite multiple improvements in surgical and non-surgical procedures, the surgical 
treatment of pancreatic cancer is still associated with high morbidity rates. Unfortunately, 
these may lead to additional surgical interventions further impairing the immune dysfunction 
of pancreatic cancer patients  [12] .
 Murine models have to include several characteristics to adequately mirror the human 
situation. First, the complex interactions of the host organism and tumour influencing neoan-
giogenesis, invasion, and formation of metastases require syngeneic models in immunocom-
petent hosts. Second, orthotopic tumour growth is critical for the tumour microenvironment 
 [13, 14] . To investigate the influence of the postoperative immune dysfunction on tumour 
growth and tumour development, we combined an animal model of surgically induced 
immune dysfunction (SID) with a pancreatic carcinoma mouse model  [15, 16] . We analysed 
survival rates and studied the tumour development employing a 7-tesla MRI. This model 
fulfilled all requirements to investigate the impact of immunosuppression on tumour disease.
 Materials and Methods 
 Laboratory Animals 
 Male C57BL/6 mice weighing 20–23 g (obtained from Charles River Laboratories, Bad Sulzfeld, 
Germany) were allowed to adapt to the new surrounding for 14 days. All animal procedures were approved 
by the Governmental Committee (Institutional Review Board) on Animal Welfare of Mecklenburg-
Vorpommern, Germany, minimizing the number of animals used. Permission was obtained from the Govern-
mental Committee (LALLF 7221.3-1.1-026/2010).
 Cell Line and Culture 
 The murine pancreatic adenocarcinoma cell line 6606PDA was a kind gift from Prof. David Tuveson, 
Cambridge, UK (current address: Cold Spring Harbor Laboratories, New York, N.Y., USA). 6606PDA cells were 
isolated from a pancreatic adenocarcinoma of a transgenic C57BL/6 mouse carrying a Kras G12D allele  [17] . 
Cells were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum, 100 U/ml of peni-
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cillin, and 100 μg/ml of streptomycin. Tissue culture reagents were obtained from Gibco (Invitrogen, 
Carlsbad, Calif., USA). Cell cultures were kept in a humidified incubator at 37  °  C with 5% CO 2 , maintained 
under pathogen-free conditions and regularly tested for  Mycoplasma species. They were consistently negative 
for  Mycoplasma contamination.
 Orthotopic Pancreatic Tumour Model 
 Pancreatic cancer cells were xenografted in mice by orthotopic injection of 6606PDA cells as described 
elsewhere  [15] . Briefly, mice were narcotised using a combination of ketamine hydrochloride (Ketanest S ® ; 
Pfizer Pharma, Berlin, Germany) and xylometazoline hydrochloride (Rompun ® ; Bayer HealthCare, Berlin, 
Germany) at concentrations of 87 and 13 mg/kg injected intraperitoneally, respectively. 20 μl of equal 
volumes of PBS and matrigel (Matrigel TM Basement Membrane Matrix; BD Bioscience, San José, Calif., USA) 
including a total amount of 2.5 × 10 5 tumour cells (6606PDA) were injected into the head of the pancreas. To 
ensure the same injection technique for all experiments, the injection was always carried out by the same 
person (M.S). To decrease postsurgical pain and side effects of surgery, we subcutaneously injected buprenor-
phine hydrochloride at a dose of 0.1 mg/kg. Survival was monitored daily for 2 months (60 days).
 Animal Model of SID 
 On days 11 and 21 following tumour implantation in mice, the intestine was manipulated as described 
before  [16] . The small intestine was pressed smoothly in an antegrade direction between two sterile cotton 
wool swabs three times consecutively. In the laparotomy group, the abdomen was only opened and closed 
after 4 min without touching the intestine. Survival analyses were performed using the Kaplan-Meier 
procedure. All mice were checked daily for their general condition over a period of 60 days.
 7-Tesla MRI 
 Tumour growth progress was analysed on days 8 and 28 after tumour injection. A detailed schedule of 
the experiment is illustrated in  figure 1 . Tumour-bearing mice were scanned in a high-field 7.0-T MRI scanner 
for small animals (ClinScan, 7.0 T, 290 mT/m gradient strength; Bruker, Ettlingen, Germany) as previously 
described  [18] . MRI analyses were performed in a whole mouse body coil (Bruker) using a T2-TSE (turbo 
spin echo) sequence. For the assessment of tumour sizes, we used high-resolution T2-weighted images of the 
coronal as well as the axial plane. The generated images were analysed employing MIPAV (Medical Imaging 
Processing and Visualisation; National Institutes of Health, Bethesda, Md., USA).
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 Fig. 1. Schedule of the experimental setup. On day 8 after tumour implantation, the tumour growth was ana-
lysed by 7-tesla MRI. Three days later (day 11 after tumour implantation), the mice underwent surgery. In 
the SID mice after laparotomy, the intestine was pressed in an antegrade direction between cotton wool 
swabs three times consecutively. In the laparotomy-only mice, the abdominal wall was closed 4 min after 
laparotomy without any abdominal organs. The control mice underwent no additional surgery. After 10 days 
(on day 21 after tumour implantation), the surgery was performed a second time. One week later (on day 28 
after tumour implantation), the tumour progress was studied by an additional MRI scan. 
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 Statistical Methods 
 Data were analysed using GraphPad Prism Version 3.02 for Windows (GraphPad Software, San Diego, 
Calif., USA). Statistical differences in the survival rates were assessed using the log-rank test and one-way 
ANOVA. A p value <0.05 was considered to be statistically significant.
 Results 
 SID Worsened the Prognosis of Tumour-Bearing Mice 
 The survival rates of tumour-bearing mice were compared between those in the SID 
group, those in the laparotomy-only group, and those in the no-surgery control group. Sixty 
days following tumour implantation, the average survival rate in SID mice was 42%, with a 
median survival of 57 days ( fig. 2 ). This result was statistically significant compared to the 
control group (75% survival rate, p < 0.02). In the laparotomy-only group, the survival rate 
was 83% and, consequently, significantly better than in SID mice (p < 0.002). The survival 
rate in control mice and laparotomy-only mice did not differ significantly (p = 0.484).
 SID Did Not Impair Tumour Size 
 On day 8 following tumour injection, the average tumour volume was 55 mm 3 in all 
groups. No additional surgery had been performed at this time point ( fig. 3 a). 
 Four weeks after tumour implantation, SID had no effect on tumour size as measured by 
MRI technology. On day 28 after tumour implantation, tumours in the SID or laparotomy-only 
mice were not significantly different in size compared to these in the control mice: the mean 
(±SEM) tumour volume was 309.1 ± 35.7, 365.4 ± 42.9, and 317.9 ± 61.1 mm 3 for SID, lapa-
rotomy-only, and control mice, respectively (p = 0.601;  fig. 3 b).
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 Fig. 2. Survival rates of the postoperative period. On days 11 and 21 after tumour implantation, the mice 
were divided into three groups: SID, laparotomy-only, or no-surgery control. Sixty days after tumour implan-
tation, the average survival rate in the no-surgery mice was 75%, whereas the SID mice showed a survival 
rate of 42%. This difference was statistically significant (control: n = 20, SID: n = 24,  * p < 0.0197). The me-
dian survival rate of the SID mice was 57 days. The laparotomy-only mice had a survival rate of 83%, which 
was significantly increased compared to that in the SID mice (laparotomy-only: n = 24,  * * p < 0.0015). 
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 SID Did Not Induce Any Morphological Changes in Tumour Development 
 MRI scans did not reveal any additional morphological changes between SID mice, lapa-
rotomy-only mice, and control mice ( fig. 4 ). Neither the zones of central necroses within the 
tumours nor the amounts of ascites were influenced by the type of surgery. Furthermore, the 
formation of metastases, including in the liver and the abdominal cavity, did not show any 
differences in all three groups.
 Discussion 
 In this study, we presented a murine model to further explore postsurgical immunosup-
pression using a syngeneic, orthotopic murine pancreatic cancer model.
 Surgical procedures are usually followed by immune dysfunction, which can last for 
several days. In case of sepsis in the postoperative period, surgically induced immunosup-
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 Fig. 3. Tumour sizes depending on the type of surgery.  a Tumour volumes were analysed by MRI on day 8 
after tumour implantation. No additional surgery had been performed at this time point. The mean tumour 
volume was 64.87 mm 3 (range 17.70–74.24), 54.99 mm 3 (range 29.92–89.50), and 52.11 mm 3 (range 8.319–
100.2) for SID mice (n = 10), laparotomy-only mice (n =10), and control mice (n = 9), respectively.  b On day 
28, the tumours of the SID mice were not significantly different from the tumours of the laparotomy-only or 
the control mice. The mean tumour volume was 309.1 mm 3 (range 198.1–472.8), 365.4 mm 3 (range 178.2–
538.8), and 317.9 mm 3 (range 172.5–457.0) for SID mice (n = 7), laparotomy-only mice (n = 8), and control 
mice (n = 4), respectively; p = 0.601. 
Control Laparotomy SID Control Laparotomy SID
Mice, n 9 10 10 Mice, n 4 8 7
Minimum 8.319 29.92 17.70 Minimum 172.5 178.2 198.1
25% percentile 41.74 32.04 26.10 25% percentile 223.6 266.7 246.3
Median 52.11 56.95 64.87 Median 321.2 397.5 271.1
75% percentile 78.26 68.96 68.86 75% percentile 412.3 438.8 393.0
Maximum 100.2 89.50 74.24 Maximum 457.0 538.8 472.8
Mean 58.06 54.99 51.61 Mean 317.9 365.4 309.1
SD 27.36 19.33 22.06 SD 122.2 121.4 94.35
SE 9.122 6.112 6.976 SE 61.11 42.93 35.66
Mean 95% CI 37.03–79.10 41.17–68.82 35.83–67.39 Mean 95% CI 123.4–512.4 263.9–466.9 221.9–396.4
Total 522.6 549.9 516.1 Total 1,272 2,923 2,164
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pression is considered to be the reason for fatalities. If peritonitis is caused by a postsurgical 
leakage or breakdown of an anastomosis, mortality is significantly increased compared to 
peritonitis induced by diverticulitis of the colon, which does not include an immunocompro-
mising surgical procedure. Based on this accepted fact, a new classification of abdominal 
sepsis was suggested: type A spontaneously acquired sepsis, and type B postoperatively 
generated sepsis  [19] . This classification has recently been revised and updated in order to 
include trauma-induced immune dysfunction in type B sepsis. Other entities, such as strokes, 
have also been added  [7] . The immune status in the postoperative period depends on the 
previous surgical trauma and is the most important factor for the organism to manage post-
operative complications.
 In addition, an efficient immune system is essential to combat tumour cells in order to 
control tumour growth. The present study describes the impact of surgically induced immu-
nosuppression on the outcome and the size of pancreatic tumours. Following tumour injection, 
the average survival rate in the no-surgery control group was 75% and did not change in the 
laparotomy-only group (sham operation) showing a survival rate of 83%. In contrast, the 
survival rate in the SID group was significantly reduced. Hence, SID significantly impaired the 
survival of mice. However, the tumour size was not affected by SID.
 In our previous studies, we described that the immune dysfunction of SID mice is induced 
by intestinal manipulation and not by laparotomy alone  [7, 20] . We could show that this effect 
correlated with the extent of the surgical trauma  [16] . Furthermore, we detected elevated 
serum corticosterone levels in SID mice but not in mice undergoing laparotomy only [unpubl. 
a b
dc
 Fig. 4. MRI of a pancreatic carci-
noma following surgery. Eight 
days following tumour implanta-
tion, tumour growth was moni-
tored by 7-tesla MRI.  a The T2-
weighted coronal slice of a mouse 
with a tumour (marked by the red 
line) is presented. On days 11 and 
21 after tumour implantation, the 
mice underwent surgery (SID or 
laparotomy only).  b The tumours 
were again analysed by MRI on 
day 28 after tumour implantation 
(coronal slice).  c An axial section 
of a different mouse on day 8 after 
tumour implantation is present-
ed. Laparotomy was performed 
on days 11 and 21 after tumour 
implantation without touching 
the intestine.  d On day 28, the tu-
mour progress was monitored by 
MRI (axial section). 
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data]. These data also suggest that serum corticosterone levels depend on the extent of the 
surgical trauma  [21] .
 In the present study, the only difference between the laparotomy group and the SID 
group was the immunocompromising manipulation of the intestine. We believe that the 
immunosuppression caused by the intestinal manipulation was the important factor inducing 
the significantly increased mortality in SID mice. In fact, we performed necropsies (data not 
shown) for possible causes of death in SID mice. However, regarding tumour volume, the 
amount of ascites, number and location of metastases as well as tumour cachexia, we could 
not find any significant differences between SID mice and control mice. In addition, we could 
not demonstrate any signs of macroscopic inflammation, including peritonitis or fibrin 
coating, for example, of the intestine. Therefore, increased mortality in SID mice is more likely 
to be caused by immunologic life-terminating reactions. Additional experiments addressing 
this issue will hopefully clarify this ‘black box’ in the future.
 The SID procedure itself has no impact on survival. At the same time, mice do not show 
any signs of sepsis or inflammation at any time following SID surgery only. In our experience, 
the immunocompromising effects last for as long as 7 days. In our model, to maintain SID 
effects, we repeated the SID procedure on day 21. Interestingly, we observed a large inter-
individual variability of tumour sizes on day 28. These results are in line with our previous 
data  [18] . However, this variability as well as the limited number of research animals 
decreased the statistical power of the experiments to detect any association between surgical 
trauma and tumour growth. Finally, we could not find a correlation between tumour volumes 
on day 8 and survival until day 28.
 As described before, the degree of intestinal trauma is the critical factor determining 
the extent of the postoperative immune dysfunction. Hence, intensification of the surgical 
trauma in the murine model results in an increased immune dysfunction as shown by 
the suppression of splenocyte cytokine release upon pro-inflammatory stimulation  [7] . 
Furthermore, there are studies that describe a slight immunostimulatory effect of very 
limited surgical procedures  [22] . Following minor surgery, the survival rate in a murine 
polymicrobial sepsis model (CASP) was increased compared to that in a group without 
previous surgical trauma  [23] . Consequently, it is important to reduce the degree of surgical 
trauma as the most crucial factor in postoperative immunosuppression and therefore in 
tumour progression in general.
 Conclusion 
 SID significantly reduces the outcome in a murine model of pancreatic cancer leaving 
tumour sizes unaffected. The here presented murine model has been developed to further 
study the impact of SID on the prognosis of pancreatic cancer.
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